WebApr 22, 2015 · Metastatic extramammary Paget's disease (EMPD) is a rare cancer with no validated systemic treatment. Regimens including FECOM 5-fluorouracil (5-FU, epirubicin, carboplatin, vincristine and mitomycin C), 5-FU/cisplatin and single agent docetaxel exhibited varying levels of efficacy in case reports. WebPigmented mammary and extramammary Paget disease are rare entities in both males and females that mimic melanoma both clinically and histologically. Furthermore, Paget disease can be associated with increased number of benign melanocytes, thus resulting in additional diagnostic difficulty, especially when only hematoxylin and eosin-stained ...

Taxotere (docetaxel) dosing, indications, interactions, adverse …

WebPaget’s disease is a rare adnexal neoplasm that was first described by Sir James Paget in . 59 . 1874(ref. 1). Extramammary Paget’s disease (EMPD) is a variant that is commonly . 60 . seen in the genital areas and anus among the senior population (ref. 2), and the number . 61 . of cases has been increasing in recent years (ref. 3). schwinn bicycle touch up paint

Paget

WebDec 6, 2024 · •Invasive extramammary Paget's disease of the vulva is rare.•Distant metastasis has a very poor prognosis.•Given rarity of disease, no standardized … WebApr 12, 2024 · Extramammary paget’s disease HER-2 trastuzumab human epidermal growth factor With strong interest, we read the review article, ‘Trastuzumab deruxtecan in HER-2-positive metastatic breast cancer and beyond’ by Perez et al. WebThere is no standard chemotherapeutic treatment for advanced extramammary Paget's disease, though the effectiveness of some chemotherapy regimens, including docetaxel, has been reported. In this report, we report that TS-1 monotherapy was effective in two patients with advanced extramammary Paget's disease after docetaxel treatment failure. prairie view school hours